典型文献
DNA Damage Response Inhibitor and Anti-PD-L1 Therapy for Prostate Cancer:Development of Predictive Biomarkers
文献摘要：
1.Introduction
Although androgen receptor biosynthesis and signaling inhibi-tors have significantly improved outcomes in patients with castra-tion-resistant prostate cancer(CRPC),there is still a dearth of effective treatment options for men with advanced prostate cancer.Recent studies have shown that DNA damage and altered DNA damage response(DDR)pathways may contribute to the progres-sion of prostate cancer to CRPC.
文献关键词：
中图分类号：
作者姓名：
Chuandong Geng;Timothy C.Thompson
作者机构：
Department of Genitourinary Medical Oncology,The University of Texas MD Anderson Cancer Center,Houston,TX 77030,USA
文献出处：
引用格式：
[1]Chuandong Geng;Timothy C.Thompson-.DNA Damage Response Inhibitor and Anti-PD-L1 Therapy for Prostate Cancer:Development of Predictive Biomarkers)[J].工程（英文）,2022(05):12-15
A类：
castra
B类：
Damage,Response,Inhibitor,Anti,L1,Therapy,Prostate,Cancer,Development,Predictive,Biomarkers,Introduction,
Although,androgen,receptor,biosynthesis,signaling,inhibi,tors,have,significantly,improved,outcomes,patients,resistant,prostate,cancer,CRPC,there,still,dearth,effective,treatment,options,advanced,Recent,studies,shown,that,damage,altered,response,DDR,pathways,may,contribute,progres,sion
AB值：
0.728511
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
